Episode Details
Back to Episodes
Episode 272: Journal Club Looking at COVID-19 Retinal Detachment Presentation, Racial and Socioeconomic Disparities in Visual Impairment, Hormone Therapy Association with Retinal Vascular Occlusion, Ranibizumab Biosimilar
Description
Drs. Nicolas Farber, Priya Vakharia, and Yoshihiro Yonekawa join for a journal club examining four publications in major ophthalmology journals.
Financial Disclosures: Dr. Sridhar is a consultant for Regeneron, Alcon, Dorc, and Oxurion. Dr. Yonekawa is a consultant for Alcon, Alimera, Allergan, and Genentech. Dr. Farber and Dr. Vakharia have no disclosures.
Retinal Detachment Presentation During COVID-19 Pandemic (https://www.aaojournal.org/article/S0161-6420(20)31006-X/fulltext)
Racial and Socioeconomic Disparities in Visual Impairment (https://www.aaojournal.org/article/S0161-6420(20)31044-7/fulltext)
Hormone Therapy Association with Retinal Vascular Occlusion (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2772809)
Ranibizumab Biosimilar Head-to-Head (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2772987)